Mediere Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 1 Year 9 Months
About Mediere Pharmaceuticals
Mediere Pharmaceuticals Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 April 2023 (One year and nine months 14 days old ). Its registered office is in Sirmaur, Himachal Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Devendra Sharma, Abhinav Kansal, Kapil Kansal, and Two other members serve as directors at the Company.
Company Details
-
Location
Sirmaur, Himachal Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U21002HP2023PTC010020
-
Company No.
010020
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Apr 2023
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Himachal Pradesh
Industry
Who are the key members and board of directors at Mediere Pharmaceuticals?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhinav Kansal
|
Director | 20-Apr-2023 | Current |
|
Devendra Sharma
|
Additional Director | 21-May-2024 | Current |
|
Kapil Kansal
|
Director | 20-Apr-2023 | Current |
|
Tejas Kansal
|
Director | 20-Apr-2023 | Current |
|
Manish Gupta
|
Director | 20-Apr-2023 | Current |
Financial Performance of Mediere Pharmaceuticals.
Enhance accessibility to Mediere Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mediere Pharmaceuticals?
Unlock access to Mediere Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Prime Fabtech Private LimitedAbhinav Kansal and Manish Gupta are mutual person
-
Hp India Metal Private Limited
Abhinav Kansal, Kapil Kansal and 1 more are mutual person
-
Rajshree Pigments Private Limited
Abhinav Kansal is a mutual person
-
Apotekare Lifesciences Private Limited
Tejas Kansal and Manish Gupta are mutual person
-
Amrit Fabtech Private Limited
Manish Gupta is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mediere Pharmaceuticals?
Unlock and access historical data on people associated with Mediere Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mediere Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediere Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.